DNB
72
4
UHS
50
4
USB
50
3
PEG
53
7
CMS
57
2
HIG
48
5
XYL
29
4
CFG
36
12
NEM
30
2
HPE
48
2
BK
60
2
AN
49
2
BDX
59
3
LMT
29
-5
PVH
58
5
JNPR
59
3
MKC
54
3
OMC
37
2
EXPE
83
8
IRM
33
5
DNB
72
4
UHS
50
4
USB
50
3
PEG
53
7
CMS
57
2
HIG
48
5
XYL
29
4
CFG
36
12
NEM
30
2
HPE
48
2
BK
60
2
AN
49
2
BDX
59
3
LMT
29
-5
PVH
58
5
JNPR
59
3
MKC
54
3
OMC
37
2
EXPE
83
8
IRM
33
5
Financhill
Back

Can Fite Biofarma Vs. Novo Nordisk AS Industry Stock Comparison

Sell
16

CANF
Can Fite Biofarma

Last Price:
$1.48
Seasonality Move:
-5.63%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
16
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.48. The Score for CANF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 35.58 Sell
Chaikin Money Flow: 104053 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.51 - 2.05) Sell
Bollinger Bands (100): (1.82 - 2.58) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.5 Sell
20-day SMA: 1.73 Sell
50-day SMA: 2.07 Sell
200-day SMA: 2.37 Sell
8-day EMA: 1.5 Sell
20-day EMA: 1.67 Sell
50-day EMA: 1.93 Sell
200-day EMA: 2.32 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):